Developing and producing new vaccines for infectious diseases.
Official title: Vaccine Manufacturing and Characterization Services
Funded at International AIDS Vaccine Initiative · NIH-9724120 · Data updated 2026-11-12
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2018 |
| Award (this year) | $60,322 |
| NIH project number | 272201800010I-0-27200001-1 |
| Project ID | NIH-9724120 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those affected by drug-resistant pathogens.
✕Less likely to help
Patients with established vaccines for their conditions may not receive direct benefits from this research.
What this research studies
This research focuses on the manufacturing and characterization of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism and drug-resistant pathogens. It involves planning and optimizing vaccine development, ensuring compliance with regulatory standards, and conducting clinical studies. Patients may benefit from the development of new vaccines that could protect against emerging and re-emerging infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of effective vaccines that protect against serious infectious diseases.
How similar studies have gone: Other research has shown success in developing vaccines using similar manufacturing and characterization approaches, indicating a promising path forward.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
-
Creating vaccines for influenza clinical trials
This study is all about creating and testing new flu vaccines to make sure they're safe and effective for people, and it aims to help bring better options to those who need them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.